Abstract:Re‐exposure to regulatory limiting nickel doses results in a clinical response in 15% in allergic individuals. Immune activation can be observed in all exposed skin areas, independent of the clinical response. Background Nickel is the leading cause of contact allergy in Europe, with 14.5% of the adult population being sensitized. Despite regulations limiting nickel release from consumer items, the incidence and prevalence of nickel allergy remain high. Objective To investigate the clinical and subclinical immune response to low‐dose nickel exposure on nickel pre‐exposed skin to assess the adequacy of current regulatory limits. Method Nickel‐allergic and healthy controls were patch tested with nickel twice with a 3–4 weeks interval. The first exposure used the diagnostic concentration of 2000 μg/cm2 nickel sulphate, and the same skin areas were then re‐exposed to 0.2, 0.5, 12.8 and 370 μg/cm2 nickel sulphate. After 48 h, the patch reactions were examined for clinical signs of eczema, and skin biopsies were collected. The transcriptomic immune profile was analysed with Nanostring nCounter and quantitative polymerase chain reaction. Results Two nickel‐allergic participants (15%) had clinical reactions to the regulatory limiting doses for nickel (0.2/0.5 μg/cm2) following re‐exposure. There was immune activation in all skin areas following re‐exposure to nickel, predominantly mediated by up‐regulation of cytokines and chemokines. In all nickel re‐exposed skin areas, 81 genes were up‐regulated independent from the clinical response. In skin areas exposed to 0.2 μg/cm2, 101 immune‐related genes were differentially expressed, even when no clinical response was observed. Healthy controls showed up‐regulation of three genes in response to nickel re‐exposures without any clinical reactions. Conclusion Immune activation can be induced in skin with local memory to nickel upon challenge with nickel doses within the regulatory limits. Our findings suggest that the regulatory limits in the European nickel regulation may not provide sufficient protection for consumers against low‐dose exposures.

Acute transient sialadenopathy associated with anesthesia.

Nickel‐elicited Systemic Contact Dermatitis

Gallium 67 citrate scanning in the diagnosis of intraabdominal abscess.

Neutrophil infiltration in allergic contact dermatitis to nickel

Metal allergy--a review on exposures, penetration, genetics, prevalence, and clinical implications

Analysis of Nickel Distribution by Synchrotron Radiation X-ray Fluorescence in Nickel-Induced Early- and Late-Phase Allergic Contact Dermatitis in Hartley Guinea Pigs

Subclinical immune responses to nickel in sensitized individuals—a dose–response study

Research Directions for Distributed Operating Systems

[Holistic nursing--do nurses take on too much?].

Nickel allergy is associated with a broad spectrum cytokine response

Nickel Sensitivity Is Associated with GH-IGF1 Axis Impairment and Pituitary Abnormalities on MRI in Overweight and Obese Subjects

Developmental Parameters and Seasonal Phenology of Calepitrimerus vitis (Acari: Eriophyidae) in Wine Grapes of Western Oregon

Patch Testing With Cobalt in Adults: A North American Contact Dermatitis Group Experience, 2001-2018

Metabolipidomic changes induced by dermal nickel penetration determined in an ex vivo porcine ear skin model

Nickel release from hairdressing tools in the United States

The Sino-American belt study: nickel and cobalt exposure, epidemiology, and clinical considerations.

Mobile Phones: Potential Sources of Nickel and Cobalt Exposure for Metal Allergic Patients

Towards understanding the unusual photoluminescence intensity variation of ultrasmall colloidal PbS quantum dots with the formation of a thin CdS shell.

Immunotoxicity of nickel: Pathological and toxicological effects

Allergic Contact Dermatitis in Psoriasis Patients: Typical, Delayed, and Non-Interacting.

2. Relevance to Public Health 2.1 Background and Environmental Exposures to Nickel in the United States